S3Z-29923-19146
2 vaccinations
4 coded responses
22 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 662 / KS
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Pfizer-BioNTech
-
2021-01-16
Registered in v-safe
- 2021-01-16
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-29
- 2021-02-05
-
2021-02-10
Dose 2 — Pfizer-BioNTech
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
-
2021-02-25
Survey response — day 14, dose 2MedDRA: Upper respiratory tract infection — Feeling: GoodFree text: Upper respiratory virusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
- 2021-03-10
- 2021-03-17
-
2021-03-26
Survey response — day 42, dose 2MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to workFree text: Cold symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-12
-
2021-08-11
Survey response — 6 months, dose 2MedDRA: Otitis media, Viral upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Middle Ear infection, upper respiratory virusMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-11
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-13
- 2022-02-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-02-10 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat
Release 4 — day 14, dose 2
Symptoms: Upper respiratory virus
Release 6 — day 42, dose 2
Symptoms: Cold symptoms
Release 9 — 6 months, dose 2
Symptoms: Middle Ear infection, upper respiratory virus
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Otitis media | ✓ | · | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
| SD | Viral upper respiratory tract infection | ✓ | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release